ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q2SCImago #7,527Hybrid

BMC Pharmacology & Toxicology

Acronym:phat
•
Abbreviation (ISO):BMC PHARMACOL TOXICO
•
Identifier (ISSN):2050-6511(Print)/1471-2210(Online)
•
Publisher:BioMed Central
Clarivate IF (2026)
3.5↑ +0.8
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for BMC Pharmacology & Toxicology

WoS Q2
12451.8620182.120192.4820212.920232.820242.720253.52026
Annual Impact Factor Metric
Current (2026):3.5
Scopus SJR & RankScopus Q2
0.752
#7,527

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
52

52 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
71articles/year
98.79% Gold OA•97.89% Original Research

Aims & Scope

BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials and toxicology.

Topics Covered (Recognized by AI)
Medicine98.1%Biology96.7%Internal medicine88%Chemistry77.9%Biochemistry71.4%Genetics69.4%Pharmacology63%Endocrinology53.4%Organic chemistry43.2%Psychology42%Pathology40.9%Physics33.4%Psychiatry32.7%Surgery28.5%Gene24.5%Receptor24.3%Cell biology23.5%Nuclear magnetic resonance22.7%Enzyme21.4%Immunology21.2%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q2
Rank134/356
IndexSCIE
JCRSCIE2026

TOXICOLOGY

Q2
Rank41/106
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q2
Rank107/356
IndexSCIE
JCISCIE2026

TOXICOLOGY

Q2
Rank35/106
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.5
Articles / Year149
Total Citations46
2025
IF2.7
Articles / Year240
Total Citations828
2024
IF2.8
Articles / Year102
Total Citations735
2023
IF2.9
Articles / Year82
Total Citations796
2022
IF—
Articles / Year98
Total Citations1,271

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,527Scopus Q2SCImago Profile
Scopus Coverage:2012-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.752

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.63

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,097 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations982
3-Year Documents271
Citable Documents270

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2
PharmacologyQ2
Pharmacology (medical)Q2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

BMC Pharmacology & Toxicology (acronym: phat, abbr: BMC PHARMACOL TOXICO, ISSN: 2050-6511) is a peer-reviewed international scholarly journal in the field of PHARMACOLOGY & PHARMACYTOXICOLOGY&nb, published by BioMed Central in England since 2012. The periodical holds a Journal Impact Factor (JIF) of 3.50, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.752 (Q2), an H-index of 52.

The journal enforces rigorous peer evaluation with an annual output of approximately 71 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,097 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
BioMed Central
Publication Language
English
Frequency
Periodic
Founding Year
2012
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: d6de2bb6-d6a9-4e53-ae09-020ce5e3ed1c
Database Updated: 2026-10-27